BioSpace News Archive

DeltaTrak®, a leading innovator of cold chain solutions, is enhancing its Cold Chain Restart Program to offer customers safer and more efficient methods to protect their employees and clients from the COVID-19 pandemic.

Quantzig, a premier analytics solutions provider, launched a comprehensive portfolio of clinical data analytics solutions as part of the company’s commitment to transform the way pharma, biopharma, and life sciences companies access market and business intelligence services for their strategic needs.

Hudson Regional Hospital has closed on its $76M purchase of the Bayonne Medical Center property and resubmitted a competitive binding offer with proof of funds to purchase the hospital operations from its current operator, CarePoint.

LUNGevity Foundation, the nation’s premier lung cancer-focused nonprofit organization, welcomes Elizabeth (Libby) Barksdale, PhD, as its new Director of Regulatory Affairs and Scientific Policy

Manhattan Scientifics, Inc. (OTCQB:MHTX) owns 50+ Million shares of its former wholly-owned subsidiary cancer diagnostic company Imagion Biosystems Ltd. (AX:IBX).

Avadim Health, Inc. (“Avadim”), a high-growth, healthcare and wellness company, today announced the acceleration of its strategy to partner with the nation’s largest urology group practices for the management of our nation’s number one infection, urinary tract infections (UTI) and patients suffering from recurrent urinary tract infections (RUTI) by utilizing Theraworx® Protect U-PAK.

Progenity, Inc., a biotechnology company with an established track record of success in developing and commercializing molecular testing products, provided corporate updates and reported financial results for the second quarter ended June 30, 2020.

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced second quarter results and provided a corporate update.

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the UBS Genomics 2.0 and MedTech Innovations Virtual Summit on Thursday, August 13, 2020 , at 3:30 p.m. ET . A live webcast of BD’s presentation can be accessed from the BD corporate website

RapidAI, the worldwide leader in advanced imaging for stroke, today announced that Rapid LVO has received Food and Drug Administration (FDA) clearance for detecting suspected LVOs (Large Vessel Occlusions). Rapid LVO helps physicians speed up triage or transfer decision-making. Working in as few as 3 minutes, Rapid LVO uses a vessel tracker in conjunction with assessment of brain regions with reduced blood vessel